SORBI, Claudia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.213
EU - Europa 4.804
AS - Asia 3.654
SA - Sud America 572
Continente sconosciuto - Info sul continente non disponibili 176
AF - Africa 110
OC - Oceania 30
Totale 17.559
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.027
IT - Italia 1.183
GB - Regno Unito 1.055
SG - Singapore 1.031
CN - Cina 904
SE - Svezia 644
DE - Germania 605
VN - Vietnam 464
HK - Hong Kong 453
BR - Brasile 437
FI - Finlandia 296
RU - Federazione Russa 230
FR - Francia 183
KR - Corea 129
BD - Bangladesh 127
UA - Ucraina 125
IN - India 115
TR - Turchia 104
CA - Canada 100
BE - Belgio 92
NL - Olanda 73
BG - Bulgaria 70
ID - Indonesia 56
IE - Irlanda 50
MX - Messico 46
JP - Giappone 43
AR - Argentina 40
PL - Polonia 37
RO - Romania 33
LT - Lituania 29
IQ - Iraq 28
IR - Iran 28
EC - Ecuador 24
ES - Italia 23
NZ - Nuova Zelanda 23
AT - Austria 22
EG - Egitto 22
CO - Colombia 19
ZA - Sudafrica 19
AE - Emirati Arabi Uniti 18
TW - Taiwan 18
CL - Cile 17
IL - Israele 17
VE - Venezuela 15
PK - Pakistan 13
KE - Kenya 12
CR - Costa Rica 11
NO - Norvegia 11
CH - Svizzera 10
KZ - Kazakistan 10
MA - Marocco 10
MY - Malesia 10
PH - Filippine 10
TH - Thailandia 10
UZ - Uzbekistan 10
SA - Arabia Saudita 9
DZ - Algeria 8
TN - Tunisia 8
AU - Australia 7
CZ - Repubblica Ceca 7
JO - Giordania 7
NG - Nigeria 7
AZ - Azerbaigian 6
CI - Costa d'Avorio 6
NI - Nicaragua 6
NP - Nepal 6
HN - Honduras 5
JM - Giamaica 5
PE - Perù 5
PY - Paraguay 5
UY - Uruguay 5
BO - Bolivia 4
BY - Bielorussia 4
DK - Danimarca 4
EU - Europa 4
LB - Libano 4
PS - Palestinian Territory 4
SN - Senegal 4
AL - Albania 3
BH - Bahrain 3
ET - Etiopia 3
LU - Lussemburgo 3
PR - Porto Rico 3
UG - Uganda 3
AO - Angola 2
DO - Repubblica Dominicana 2
EE - Estonia 2
HU - Ungheria 2
MM - Myanmar 2
OM - Oman 2
RS - Serbia 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TG - Togo 2
AF - Afghanistan, Repubblica islamica di 1
BB - Barbados 1
BN - Brunei Darussalam 1
BZ - Belize 1
CG - Congo 1
CY - Cipro 1
Totale 17.365
Salva come PNG Salva come JPEG
Città #
Ashburn 712
Santa Clara 664
Southend 644
Singapore 635
Fairfield 519
Hong Kong 430
San Jose 393
Chandler 389
Woodbridge 353
Ann Arbor 329
Munich 324
Chicago 305
Hefei 282
Nyköping 280
Houston 276
Seattle 259
Council Bluffs 243
New York 241
Jacksonville 224
Helsinki 218
Beijing 205
Wilmington 193
Modena 190
Dearborn 189
Cambridge 187
Los Angeles 179
London 150
Ho Chi Minh City 146
Hanoi 105
Seoul 98
Brussels 91
Milan 91
Salt Lake City 83
The Dalles 78
Sofia 66
San Diego 62
Eugene 53
Princeton 53
Elk Grove Village 52
Lauterbourg 50
Bologna 47
Dublin 47
Izmir 46
Orem 45
Columbus 44
São Paulo 44
Buffalo 40
Dallas 40
Moscow 40
Tampa 40
Tokyo 40
Amsterdam 36
Fremont 35
Toronto 35
Da Nang 33
Jakarta 33
Rome 32
Shanghai 29
Frankfurt am Main 28
Redwood City 28
Boardman 27
Bremen 25
Mexico City 25
Warsaw 25
Auckland 23
Turku 23
Sochi 22
Phoenix 20
Sterling 20
Yalova 20
Brooklyn 19
Reggio Emilia 19
Chennai 18
Mumbai 18
Augusta 17
Norwalk 17
Haiphong 16
Montreal 16
Parma 16
Philadelphia 16
Atlanta 15
Denver 15
Grafing 15
Jyväskylä 15
Boston 14
Guangzhou 14
Naples 14
San Francisco 14
Des Moines 13
Kent 13
Lancaster 13
Paris 13
Stockholm 13
Baghdad 12
Hillsboro 12
Horia 12
Leawood 12
Manchester 12
Zanjan 12
Dhaka 11
Totale 11.469
Salva come PNG Salva come JPEG
Nome #
1,3-Dioxolane-Based Ligands Incorporating a Lactam or Imide moiety: Structure-Affinity/Activity Relationship at alpha1–Adrenoceptor subtypes and at 5-HT1A Receptors 754
(2,2-difenil-[1,3]-diossolan-4ilmetil)-(3-fenil-propil)-ammina: nuovo agonista parziale del recettore serotoninergico 5-HT1A 648
1,3-Dioxane as a scaffold for potent and selective 5-HT1AR agonist with in-vivo anxiolytic, anti-depressant and anti-nociceptive activity 583
1,3-Dioxolane-Based Ligands as a Novel Class of Alpha1-Adrenoceptor Antagonists 532
1,3-Dioxolane-Based Ligands as Rigid Analogues ofNaftopidil: Structure–Affinity/Activity Relationships at a1and 5-HT1A Receptors 501
1,4-Dioxolane-triazaspirodecanone derivatives as nociceptin/orphanin FQ receptor ligands 461
1,3-dioxolane-based ligands in the search for alpha1-adrenergic antagonists. 454
Enantiomeric resolution of [(2,2-diphenyl-1,3-dioxolan-4-yl)methyl](2-phenoxyethyl)amine, a potent α1and 5-HT1Areceptor ligand: an in vitro and computational study 451
(2,2-Diphenyl-[1,3]oxathiolan-5-ylmethyl)-(3-phenylpropyl)-amine: a Potent and Selective 5-HT1A Receptor Agonist 449
Discovery of a new 5-HT1A receptor agonist, acting ‘in vivo’ in a rat model of anxiety and depression 432
A New and Versatile Synthesis of 1,3-Dioxan-5-yl-pyrimidine and Purine Nucleoside Analogues 396
A homology modelling-driven study leading to the discovery of the first mouse trace amine-associated receptor 5 (TAAR5) antagonists 382
Discovery Of New Sigma-2 Receptor Agonist Endowed With Antiproliferative Activity 371
Synthesis, biological evaluation and molecular modeling of 1-oxa-4-thiaspiro- and 1,4-dithiaspiro[4.5]decane derivatives as potent and selective 5-HT1A receptor agonists 358
Diastereoselective Synthesis of (1,3-Dioxan-4-yl)pyrimidine and Purin Nucleoside Analogues 347
Structure-Activity Relationship within a new series of σ1 and σ2 receptor ligands: identification of a novel σ2R agonist (BS148) with selective toxicity against metastatic melanoma 346
Structure-affinity/activity relationships of 1,4-dioxa-spiro[4.5]decane based ligands at α1 and 5-HT1A receptors 339
Synthesis and structure-activity relationships of 1-aralkyl-4- benzylpiperidine and 1-aralkyl-4-benzylpiperazine derivatives as potent σ ligands 333
Discovery of a new series of 5-HT1A receptor agonists 333
Synthesis of 6-O-methotrexylhyaluronan as a drug delivery system 332
Investigation of the effect of different linker chemotypes on the inhibition of histone deacetylases (HDACs) 313
Scouting Sigma Receptor Ligands As New Tools For The Treatment Of Neurodegenerative Diseases And Cancer 305
Synthesis and biological evaluation of 1,3-dioxolane-based 5-HT 1A receptor agonists for CNS disorders and neuropathic pain 305
DAT atypical inhibitors as novel antipsychotic drugs 303
Synthesis, structural characterization and biological evaluation of 4′-C-methyl- and phenyl-dioxolane pyrimidine and purine nucleosides 299
BS148 Reduces the Aggressiveness of Metastatic Melanoma via Sigma-2 Receptor Targeting 294
Synthesis, biological evaluation and molecular modelling of 1-oxa-4-thiaspiro- and 1,4-dithiaspiro[4.5]decane derivatives as potent and selective 5-HT1A receptor agonists 283
Exhaustive CoMFA and CoMSIA analyses around different chemical entities: A ligand-based study exploring the affinity and selectivity profiles of 5-HT1A ligands 281
Structure-activity relationship at alpha-adrenergic receptors within a series of imidazoline analogues of cirazoline 276
Transacetalization of Acetals with Butane-1,2,4-triol Using Cobalt(II) Chloride and Chlorotrimethylsilane 274
Synthesis and Structure-Activity Relationships of Triazaspirodecanone Derivatives as Nociceptin/Orphanin FQ Receptor Ligands 269
Synthesis of 5-Methyl-1,3-oxathiolane-based Nucleoside Analogues as Potential Antiviral Agents 264
Discovery of potent pyrrolo-pyrimidine and purine HDAC inhibitors for the treatment of advanced prostate cancer 252
Structure Activity Relationships at 5-HT1A receptors within a novel series of 4-alkyl-1-arylpiperazine derivatives 248
Pyrrolidine Derivatives as New Ligands for 5-HT1A Receptors 247
Novel Dithiolane-Based Ligands Combining Sigma and NMDA Receptor Interactions as Potential Neuroprotective Agents 247
Synthesis, enantiomeric separation and docking studies of spiropiperidine analogues as ligands of the nociceptin/orphanin FQ receptor 245
Effect of the rigidification of propranolol, a mixed β-adrenoceptor and 5-HT1AR antagonist 245
Identification of a Potent and Selective 5-HT1AReceptor Agonist with In Vitro and In Vivo Antinociceptive Activity 239
Constrained 1,4-dialkylpiperazines as monoamine transporters inhibitors for cocaine-related abuse 239
Synthesis, absolute configuration and antimuscarinic activity of the enantiomers of [1-(2,2-diphenyl-[1,3]dioxolan-4-yl)-ethyl]dimethyl-amine 229
Inhibitors of histone deacetylase 6 based on a novel 3-hydroxy-isoxazole zinc binding group 222
Effect of the replacement of the o-methoxyphenyl moiety with nitrogen-containing aromatic rings within N-phenyl-piperazine and phenoxy-ethylamine-based 1,3-dioxo/oxathio/dithiolanes as α1 and 5-HT1A receptor ligands 209
Synthesis, structural characterization and pharmacological evaluation of spiroxatrine analogs as potential nociceptin/orphanin FQ receptor ligands 207
Novel S1R agonists counteracting NMDA excitotoxicity and oxidative stress: A step forward in the discovery of neuroprotective agents 205
Derivati 1,3-Diossanici come Antagonisti Muscarinici 204
1,3-Dithiolane as a Privileged Scaffold in Bioactive Derivatives: Chiral Resolution and Assignment of Absolute Configuration 203
Synthesis and biological evaluation of Hsp90/HDAC6 dual inhibitors bearing a 2-amino-pyrrolopyrimidine and purine scaffold as potential anticancer drugs to treat prostate cancer 191
Spiroxatrine derivatives towards 5-HT1A receptor selectivity 190
Synthesis and structural characterization of spiroxatrine derivatives as potential non-peptide ligands for NOP receptor 189
Relazioni struttura-attività in una nuova serie di ligandi alpha1-adrenergici e 5-HT1A serotoninergici a struttura 2,2-difenil-[1,3]diossolanica 188
IDENTIFICATION OF POTENT 1,3-DIOXOLANE-BASED 5-HT1A RECEPTOR AGONISTS FOR THE TREATMENTS OF CNS DISORDERS AND PAIN 186
Synthesis and pharmacological evaluation of Spiroxatrine derivatives as potential ligands for NOP receptor 182
Nuova Serie di Ligandi Sigma a Struttura Piperazinica e Piperidinica 178
TB62, A POTENT 5-HT1A SEROTONERGIC FULL AGONIST, ENDOWED WITH DUAL ANTINOCICEPTIVE AND ANXIOLITIC/ANTIDEPRESSANT ACTIVITY 161
Structure-Activity Relationships at alpha1-Adrenoceptor Subtypes within a New Series of 1,3-Dioxolane Derivatives 145
Insights into the Structural Conformations of the Tau Protein in Different Aggregation Status 122
Farmaci attivi sul sistema nervoso adrenergico 94
Structure-Based Discovery of Hsp90/HDAC6 Dual Inhibitors Targeting Aggressive Prostate Cancer 24
Totale 17.559
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.850
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.850
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.128 0 106 77 90 49 95 38 65 175 86 206 141
2022/20231.406 221 168 114 151 147 163 42 107 163 46 59 25
2023/2024948 20 51 99 103 216 86 58 126 9 38 69 73
2024/20253.334 161 41 72 163 487 443 472 285 323 156 319 412
2025/20265.639 370 223 462 789 1.069 341 671 289 481 421 277 246
2026/2027389 154 235 0 0 0 0 0 0 0 0 0 0
Totale 17.559